کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6151155 1231506 2014 14 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Design and methods of “diaBEAT-it!”: A hybrid preference/randomized control trial design using the RE-AIM framework
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی و دندانپزشکی (عمومی)
پیش نمایش صفحه اول مقاله
Design and methods of “diaBEAT-it!”: A hybrid preference/randomized control trial design using the RE-AIM framework
چکیده انگلیسی

BackgroundDiabetes prevention is a public health priority that is dependent upon the reach, effectiveness, and cost of intervention strategies. However, understanding each of these outcomes within the context of randomized controlled trials is problematic.PurposeTo describe the methods and design of a hybrid preference/randomized control trial using the RE-AIM framework.MethodsThe trial, which was developed using the RE-AIM framework, will contrast the effects of 3 interventions: (1) a standard care, small group, diabetes prevention education class (SG), (2) the small group intervention plus 12 months of interactive voice response telephone follow-up (SG-IVR), and (3) a DVD version of the small group intervention with the same IVR follow-up (DVD-IVR). Each intervention includes personal action planning with a focus on key elements of the lifestyle intervention from the Diabetes Prevention Program (DPP). Adult patients at risk for diabetes will be randomly assigned to either choice or RCT. Those assigned to choice (n = 240) will have the opportunity to choose between SG-IVR and DVD-IVR. Those assigned to RCT group (n = 360) will be randomly assigned to SG, SG-IVR, or DVD-IRV. Assessment of primary (weight loss, reach, & cost) and secondary (physical activity, & dietary intake) outcomes will occur at baseline, 6, 12, and 18 months.ConclusionThis will be the first diabetes prevention trial that will allow the research team to determine the relationships between reach, effectiveness, and cost of different interventions.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Contemporary Clinical Trials - Volume 38, Issue 2, July 2014, Pages 383-396
نویسندگان
, , , , , , , , ,